Global Hyoscine Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hyoscine Market Insights, Forecast to 2034
Hyoscine, also referred as scopolamine, is utilized as a medicine to treat motion sickness, gastrointestinal spasms, vomiting, and postoperative nausea. In addition, it is utilized sometimes before surgery to decrease saliva. Hyoscine belongs to antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.
Global Hyoscine market is expected to reach to US$ 465.5 million in 2024, with a positive growth of %, compared with US$ 442.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hyoscine industry is evaluated to reach US$ 617.1 million in 2029. The CAGR will be 4.8% during 2024 to 2029.
The increased incidence of motion sicknesses such as nausea and vomiting further led to the adoption of hyoscine medicines. Additionally, the market's growth is aided by increased research in the field of Hyoscine. For instance, an article published on April 2022 by BMC Journal showed that pre-treatment with intravenous hyoscine butyl-bromide (HBB) is a risk-free method for both the mother and the child in cesarean section patients undergoing spinal anesthesia to lower the risk of severe intraoperative bradycardia. Furthermore, the increase in travel worldwide is likely to boost the hyoscine market since motion sickness is mainly treated with hyoscine. For instance, as per the June 2022 report from UNWTO, the latest World Tourism Barometer showed an increase of 182% for international tourism in the first three months of 2022 compared to the previous year.
Report Covers
This report presents an overview of global Hyoscine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Hyoscine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Alchem International Ltd.
Alkaloids Corporation
Baxter International Inc.
Caleb Pharmaceuticals, Inc.
Centroflora Cms S. R.L.
GlaxoSmithKline Plc
Guangzhou Hanfang Pharmaceutical Co., Ltd.
Myungmoon Pharma Co., Ltd.
Novartis International AG
Perrigo Company Plc
Boehringer-Ingelheim
Linnea
C2 PHARMA
Segment by Type
Hyoscine Butylbromide
Hyoscine Hydrobromide
Oral
Injections
Patches
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Hyoscine plant distribution, commercial date of Hyoscine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Hyoscine introduction, etc. Hyoscine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Hyoscine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Hyoscine market is expected to reach to US$ 465.5 million in 2024, with a positive growth of %, compared with US$ 442.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hyoscine industry is evaluated to reach US$ 617.1 million in 2029. The CAGR will be 4.8% during 2024 to 2029.
The increased incidence of motion sicknesses such as nausea and vomiting further led to the adoption of hyoscine medicines. Additionally, the market's growth is aided by increased research in the field of Hyoscine. For instance, an article published on April 2022 by BMC Journal showed that pre-treatment with intravenous hyoscine butyl-bromide (HBB) is a risk-free method for both the mother and the child in cesarean section patients undergoing spinal anesthesia to lower the risk of severe intraoperative bradycardia. Furthermore, the increase in travel worldwide is likely to boost the hyoscine market since motion sickness is mainly treated with hyoscine. For instance, as per the June 2022 report from UNWTO, the latest World Tourism Barometer showed an increase of 182% for international tourism in the first three months of 2022 compared to the previous year.
Report Covers
This report presents an overview of global Hyoscine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Hyoscine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Alchem International Ltd.
Alkaloids Corporation
Baxter International Inc.
Caleb Pharmaceuticals, Inc.
Centroflora Cms S. R.L.
GlaxoSmithKline Plc
Guangzhou Hanfang Pharmaceutical Co., Ltd.
Myungmoon Pharma Co., Ltd.
Novartis International AG
Perrigo Company Plc
Boehringer-Ingelheim
Linnea
C2 PHARMA
Segment by Type
Hyoscine Butylbromide
Hyoscine Hydrobromide
Segment by Application
Oral
Injections
Patches
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Hyoscine plant distribution, commercial date of Hyoscine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Hyoscine introduction, etc. Hyoscine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Hyoscine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports